Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Psych CASC / OSCEOld age psychiatry — residential care and systems of care

Psych CASC / OSCE · Old age psychiatry — residential care and systems of care

Explain antipsychotic risk and a non-drug plan to a residential care manager — CASC communication station

MRCPsych/FRANZCP-style communication station: explain RAC behavioural assessment, person-centred care evidence, antipsychotic mortality risk, limited indications, chemical restraint concerns, and collaborative plan.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
The care manager of a residential aged care facility wants standing antipsychotics for several residents who call out or wander. She is frustrated after a staff injury during personal care of one resident with dementia. She asks why psychiatrists 'always say no to tablets' and wants a clear plan she can take to her team.

Station brief

Format. Communication station, approximately 7–10 minutes active time after reading. You are the old-age psychiatry registrar on a residential care liaison visit. [1]

Candidate instructions. Acknowledge staff injury and facility pressures; explain multifactorial behaviour (medical causes, pain, unmet needs, care approach); outline non-drug and staff-training plans with plain-language evidence; explain why antipsychotics are not first-line for wandering or calling out and carry death/fall risks; clarify when a short low-dose course might still be used with review; address chemical restraint and documentation; agree a written collaborative plan and follow-up. Examiner plays the care manager. [1][2][3]

Candidate scenario

Several residents call out or wander. One man with dementia struck a carer during showering last week. The manager wants standing risperidone for "anyone who is unsettled." No systematic pain protocol or behaviour charts are in place. Your task is collaborative systems advice, not confrontation. [1][5]

Marking domains

  • Empathy with staff safety concerns and facility workload
  • Accurate multifactorial explanation without blaming staff
  • Clear non-drug plan (person-centred care, training, pain protocol)
  • Honest antipsychotic harm discussion and narrow indications
  • Shared plan, documentation, review, and teach-back [1][2][3][4]
Reveal assessor key

Open and agenda-set. Acknowledge the staff injury and fear. Name two agendas: safety of staff and residents, and safer evidence-based care. Avoid lecturing tone. [1]

Explain the model. "Behaviour in dementia is usually a signal — pain, infection, constipation, fear during personal care, under-stimulation or overstimulation — not simply a chemical deficiency of risperidone. Wandering and calling out are common and usually need supervision and activity redesign, not antipsychotics." [1]

Non-drug plan. Propose behaviour charts, pain protocol (name that treating pain can reduce behavioural disturbance), person-centred personal care techniques, and staff training packages shown to reduce antipsychotic use without chaos (Fossey/WHELD-style language: training and meaningful activity help quality of life and can lower drug reliance). Offer liaison coaching sessions. [3][4][5]

Medicines. "Antipsychotics can sometimes help severe aggression or distressing psychosis for a short time, but trials show increased risk of death in people with dementia, plus falls and sedation. They are not for wandering or mild restlessness. If we use a medicine, it will be the lowest dose, short period, clear target, consent or proxy, and a stop date." [2]

Close. Summarise written plan: medical review of the aggressive resident today; pain and constipation check; care-approach change for showers; no standing antipsychotic for callers/wanderers; optional short targeted prescription only if residual severe danger after non-drug measures; review in one week; restrictive-practice documentation standards. Teach-back and offer contact for urgent escalation. [1][2][3]

References

  1. [1]Kales HC, Gitlin LN, Lyketsos CG Assessment and management of behavioral and psychological symptoms of dementia BMJ, 2015.PMID 25731881
  2. [2]Schneider LS, Dagerman KS, Insel P Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials JAMA, 2005.PMID 16234500
  3. [3]Fossey J, Ballard C, Juszczak E, et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial BMJ, 2006.PMID 16543297
  4. [4]Ballard C, Corbett A, Orrell M, et al. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial PLoS Med, 2018.PMID 29408901
  5. [5]Husebo BS, Ballard C, Sandvik R, et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial BMJ, 2011.PMID 21765198